4//SEC Filing
Pacira Pharmaceuticals, Inc. 4
Accession 0001181431-15-004886
$PCRXCIK 0001396814operating
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 6:59 PM ET
Size
7.7 KB
Accession
0001181431-15-004886
Insider Transaction Report
Form 4
Markvicka Taunia
Vice President, Commercial
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2015-03-17−8,349→ 0 totalExercise: $5.49Exp: 2020-12-28→ Common Stock (8,349 underlying) - Exercise/Conversion
Common Stock
2015-03-17$5.49/sh+8,349$45,836→ 8,579 total
Holdings
- 230(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Includes 230 shares of common stock acquired under the issuer's employee stock purchase plan in December 2014.
- [F2]The stock option vests as follows: 25% of the options vested on December 29, 2011, and the remaining options vested in successive equal monthly installments over the subsequent 36 months.
Documents
Issuer
Pacira Pharmaceuticals, Inc.
CIK 0001396814
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001396814
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 6:59 PM ET
- Size
- 7.7 KB